MedTrace Logo

Observational Study on the Patients With Rectal Cancer

NCT02312284 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3995

Last updated 2016-01-18

No results posted yet for this study

Summary

The aim of this observational study is to retrospectively collect current survival data for 3995 primary rectal cancer patients who were extracted from 5097 rectal cancer patients admitted in Cancer Hospital, Chinese Academy of Medical Sciences from January 2000 to December 2010. Moreover, based on a Cox model, we want to develope a nomogram that predicts local recurrence, distant metastases, and survival for patients with rectal cancer treated with pre- or postoperative chemoradiotherapy (CRT).

Conditions

  • Rectal Cancer
  • Adjuvant Chemoradiotherapy
  • Neoadjuvant Chemoradiotherapy
  • Adjuvant Chemotherapy
  • Surgery

Sponsors & Collaborators

  • Chinese Academy of Medical Sciences

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02312284 on ClinicalTrials.gov